266 related articles for article (PubMed ID: 25694606)
21. KSHV inhibits stress granule formation by viral ORF57 blocking PKR activation.
Sharma NR; Majerciak V; Kruhlak MJ; Zheng ZM
PLoS Pathog; 2017 Oct; 13(10):e1006677. PubMed ID: 29084250
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellular RNA decay pathways.
Sahin BB; Patel D; Conrad NK
PLoS Pathog; 2010 Mar; 6(3):e1000799. PubMed ID: 20221435
[TBL] [Abstract][Full Text] [Related]
23. The evolutionarily conserved Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with REF protein and acts as an RNA export factor.
Malik P; Blackbourn DJ; Clements JB
J Biol Chem; 2004 Jul; 279(31):33001-11. PubMed ID: 15155762
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma-associated herpesvirus lytic gene ORF57 is essential for infectious virion production.
Han Z; Swaminathan S
J Virol; 2006 Jun; 80(11):5251-60. PubMed ID: 16699005
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide regulation of KSHV RNA splicing by viral RNA-binding protein ORF57.
Majerciak V; Alvarado-Hernandez B; Lobanov A; Cam M; Zheng ZM
PLoS Pathog; 2022 Jul; 18(7):e1010311. PubMed ID: 35834586
[TBL] [Abstract][Full Text] [Related]
26. Cell-based screening assay for antiviral compounds targeting the ability of herpesvirus posttranscriptional regulatory proteins to stabilize viral mRNAs.
Verma D; Kim EA; Swaminathan S
J Virol; 2013 Oct; 87(19):10742-51. PubMed ID: 23903829
[TBL] [Abstract][Full Text] [Related]
27. The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target.
Abere B; Mamo TM; Hartmann S; Samarina N; Hage E; Rückert J; Hotop SK; Büsche G; Schulz TF
PLoS Pathog; 2017 Sep; 13(9):e1006639. PubMed ID: 28938025
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma-associated herpesvirus ORF57 interacts with cellular RNA export cofactors RBM15 and OTT3 to promote expression of viral ORF59.
Majerciak V; Uranishi H; Kruhlak M; Pilkington GR; Massimelli MJ; Bear J; Pavlakis GN; Felber BK; Zheng ZM
J Virol; 2011 Feb; 85(4):1528-40. PubMed ID: 21106733
[TBL] [Abstract][Full Text] [Related]
29. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
30. Structural identification of conserved RNA binding sites in herpesvirus ORF57 homologs: implications for PAN RNA recognition.
Tunnicliffe RB; Levy C; Ruiz Nivia HD; Sandri-Goldin RM; Golovanov AP
Nucleic Acids Res; 2019 Feb; 47(4):1987-2001. PubMed ID: 30462297
[TBL] [Abstract][Full Text] [Related]
31. Screening of the Human Kinome Identifies MSK1/2-CREB1 as an Essential Pathway Mediating Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication during Primary Infection.
Cheng F; Sawant TV; Lan K; Lu C; Jung JU; Gao SJ
J Virol; 2015 Sep; 89(18):9262-80. PubMed ID: 26109721
[TBL] [Abstract][Full Text] [Related]
32. Mutation of a C-terminal motif affects Kaposi's sarcoma-associated herpesvirus ORF57 RNA binding, nuclear trafficking, and multimerization.
Taylor A; Jackson BR; Noerenberg M; Hughes DJ; Boyne JR; Verow M; Harris M; Whitehouse A
J Virol; 2011 Aug; 85(15):7881-91. PubMed ID: 21593148
[TBL] [Abstract][Full Text] [Related]
33. An interaction between KSHV ORF57 and UIF provides mRNA-adaptor redundancy in herpesvirus intronless mRNA export.
Jackson BR; Boyne JR; Noerenberg M; Taylor A; Hautbergue GM; Walsh MJ; Wheat R; Blackbourn DJ; Wilson SA; Whitehouse A
PLoS Pathog; 2011 Jul; 7(7):e1002138. PubMed ID: 21814512
[TBL] [Abstract][Full Text] [Related]
34. Interplay between polyadenylate-binding protein 1 and Kaposi's sarcoma-associated herpesvirus ORF57 in accumulation of polyadenylated nuclear RNA, a viral long noncoding RNA.
Massimelli MJ; Majerciak V; Kruhlak M; Zheng ZM
J Virol; 2013 Jan; 87(1):243-56. PubMed ID: 23077296
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's Sarcoma-Associated Herpesvirus mRNA Accumulation in Nuclear Foci Is Influenced by Viral DNA Replication and Viral Noncoding Polyadenylated Nuclear RNA.
Vallery TK; Withers JB; Andoh JA; Steitz JA
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643239
[TBL] [Abstract][Full Text] [Related]
36. The crystal structure of KSHV ORF57 reveals dimeric active sites important for protein stability and function.
Yuan F; Gao ZQ; Majerciak V; Bai L; Hu ML; Lin XX; Zheng ZM; Dong YH; Lan K
PLoS Pathog; 2018 Aug; 14(8):e1007232. PubMed ID: 30096191
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYM to enhance translation of viral intronless mRNAs.
Boyne JR; Jackson BR; Taylor A; Macnab SA; Whitehouse A
EMBO J; 2010 Jun; 29(11):1851-64. PubMed ID: 20436455
[TBL] [Abstract][Full Text] [Related]
38. KSHV RNA-binding protein ORF57 inhibits P-body formation to promote viral multiplication by interaction with Ago2 and GW182.
Sharma NR; Majerciak V; Kruhlak MJ; Yu L; Kang JG; Yang A; Gu S; Fritzler MJ; Zheng ZM
Nucleic Acids Res; 2019 Sep; 47(17):9368-9385. PubMed ID: 31400113
[TBL] [Abstract][Full Text] [Related]
39. Delineation of a core RNA element required for Kaposi's sarcoma-associated herpesvirus ORF57 binding and activity.
Sei E; Conrad NK
Virology; 2011 Oct; 419(2):107-16. PubMed ID: 21889182
[TBL] [Abstract][Full Text] [Related]
40. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.
Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W
J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
